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Structure-Based Design of Phospholamban Mutants for Treatment of
Heart Failure
Simon J. Gruber, David D. Thomas.
Ca2þ cycling through the SR in muscle cells is largely controlled by the Ca-
pump (SERCA). SERCA transports Ca2þ into the SR, allowing muscles to re-
lax, and is inhibited by phospholamban (PLB) at submicromolar [Ca2þ]. PLB
inhibition can be relieved by adrenergic stimulation, leading to PLB phosphor-
ylation. Heart Failure (HF), which contributes to 12% of US deaths, can be
caused by a variety of genetic or environmental factors, but a common symp-
tom is decreased SERCA activity. We are using EPR and NMR to study the
relationships among structure, dynamics, and function of PLB, with the goal
of designing LOF-PLB mutants (PLBM) that can compete with WT-PLB and
thus relieve SERCA inhibition. Several studies have shown that a pseudophos-
phorylated PLB (S16E-PLB) is effective for gene therapy in rodents and sheep,
and we are using spectroscopic methods to refine this approach. We have de-
veloped a system for examining the function and interactions of SERCA and
PLB in HEK cells. Active SERCA is expressed and cells are co-transfected
with WT-PLB and/or PLBM to measure SERCA inhibition in living cells. Ef-
fects of PLB/PLBM on SERCA specific activity (s
1), as well as PLB oligo-
meric states are characterized in stable cells lines. We can also measure
a mutant’s ability to compete with WT-PLB by measuring fluorescence reso-
nance energy transfer (FRET) between labeled SERCA and WT-PLB. If
PLBM displaces WT-PLB, less energy is transferred between fluorophores
and a decrease in FRET is observed. Preliminary results have led to rAAV-
mediated expression of a PLBM (P21G) in cardiomyocytes of a rat HF model,
increasing contractility to near WT levels.
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Analyzing the Role of NCKX2 in Hippocampal Long Term Potentiation
Yuntian Zhang, Ray W. Turner, Jonathan Lytton.
Naþ/Ca2þ exchangers control clearance of cytosolic Ca2þ following a sig-
naling event when Ca2þ is elevated due to their low-affinity/high capacity
transport properties. NCKX2 is a member of the family of Kþ-dependent
Naþ/Ca2þ-exchangers, and is abundant in brain neurons. Targeted knock-
out of the NCKX2 gene results in a profound loss of long term potentiation
and an increase in long term depression at hippocampal Schaffer/CA1 syn-
apses. We examined the expression of a variety of synaptic molecules when
NCKX2 is knocked out to disclose the role of NCKX2 in hippocampal
plasticity. Co -localization experiments using confocal and electron micros-
copy were conducted to define the location of NCKX2 in hippocampus. Im-
munoblot results from whole brain lysates showed that GluR2/3 and
NMDA-receptor 1 were reduced in NCKX2 knockout mice. There was
no statistical difference in immunoblot for CamKII, PSD95, or GluR1 be-
tween wild type and the knockout. In hippocampus phospho-CamKII was
upregulated, and small but insignificant changes were found in the expres-
sion of other synaptic marker proteins. Co-localization analyses showed
minimal overlap of NCKX2 with either the post synaptic marker CamKII
or the presynaptic markers synapsin, synaptophysin or VGLUT-1. Immuno-
cytochemistry revealed a decrease in net MAP-2 label in the CA3 region of
knockout animals that correlates to a reduction in the number of neuronal
profiles and increase in DAPI-labeled nuclei, suggesting neuronal loss and
glial cell proliferation. From the above experiments, we can for first time
approach the idea of the exact location of NCKX2. Expression change
for various synaptic molecules in hippocampus is not obvious, but rather
loss of CA3 neurons and the associated Schaeffer collateral projection to
CA1, potentially resulting from changes in calcium dynamics when
NCKX2 is knocked out.
Protein Ligand Interactions: Receptors & Small
Molecules
2981-Pos Board B86
Anesthetic Modulation of Signal Transduction Pathways in the a4b2
nAchR Revealed by the Perturbation-Based Markovian Transmission
Model
Lu Tian Liu, Mingzhu Li, David Mowrey, Hsiao-Mei Lu, Jie Liang, Yan Xu,
Pei Tang.
The gating mechanism of ligand-gated ion channels and anesthetic modulation
of channel gating remain to be determined. In this study, we used the
perturbation-based Markovian transmission model to investigate the time-
dependent signal propagation in the neuronal nicotinic acetylcholine receptor
(a4b2 nAChR) under initial perturbations by agonist binding. Both open-and closed-channel a4b2 nAChR conformations in the presence and absence
of the anesthetic halothane, from our previous computational studies, were ex-
amined. We found that signal transduction in a4b2 resembles the conformation
wave mechanism. In all systems, the perturbation signal flows from the agonist-
binding sites up toward the main immunogenic region, then down to the bottom
of the beta barrel, followed by the extracellular (EC)/transmembrane (TM) in-
terface, and finally to the transmembrane domain, as measured by the time de-
pendence of the maximum probability flux. The EC domain of the open- and
closed-channel a4b2 conformations showed different dynamic responses to
the perturbation at the agonist-binding site: many more residues in the EC do-
main of the open-channel a4b2 nAChR exhibited frequent fluctuation. In the
system with halothane, the signal transduction within pre-TM1 (R207), Cys-
loop (F137, P138, F139), and TM2-TM3 linker (L271) slowed down in some
of the subunits, but speeded up in others. The changes in signal transduction
at the EC/TM interface may underlie the effects of anesthetics on the a4b2
nAChR. Supported by NIH (R01GM066358, R01GM056257,
R37GM049202).
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Catharanthine Alkaloids are Noncompetitive Inhibitors of Muscle-Type
Nicotinic Acetylcholine Receptors
Ruin Moaddel.
This is an attempt to characterize the binding sites and the mechanisms of
action of several catharanthine alkaloids including ibogaine, vincristine,
and vinblastine, on muscle-type nicotinic acetylcholine receptors (AChRs),
by comparing their pharmacological properties with that for the well charac-
terized high-affinity noncompetitive antagonist (NCA) phencyclidine (PCP).
In this regard, structural and functional approaches were used including ra-
dioligand equilibrium and competition binding assays using [3H]ibogaine
and the analog of PCP, [piperidyl-3, 4-3H(N)]-N-(1-(2 thienyl)cyclohexyl)-
3,4-piperidine ([3H]TCP), Ca2þ influx determinations, thermodynamic and
kinetic measurements using column-immobilized Torpedo AChRs, and mo-
lecular docking and dynamics studies The results established that: (a) the al-
kaloidsinhibit (5)-epibatidine-induced Ca2þ influx in embryonic muscle
AChRs with the following potencies (in mM): ibogaine (17 5 3) > vinblas-
tine (20 5 5) > vincristine (25 5 4), that are slightly higher than that for
PCP (31 5 2), (b) the alkaloids inhibit [3H]TCP binding, and ibogaine
and PCP inhibit [3H]ibogaine binding, to the desensitized Torpedo AChR
with higher affinity compared to the resting AChR, (c) ibogaine binds to
the Torpedo AChR by an entropy-driven process, and (d) ibogaine interacts
with a binding domain located between the serine (position 6’) and valine
(position 13’) rings, by a network of van der Waals and polar interactions.
Collectively our data indicate that catharanthine alkaloids block agonist-
activated ion channels by interacting with a binding domain that is shared
with PCP located between the serine and valine rings. This supports the
view that the catharanthine moiety, which is shared by ibogaine and vinca
alkaloids, is a minimum structural requirement for the interaction of these
molecules with the ion channel. In addition, ibogaine and vinca alkaloids
may induce and maintain the desensitized state by a mechanism where their
dissociation rates are decreased.
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A Combined Experimental and Simulation Approach to Develop Selective
High-Affinity Small-Molecule Inhibitors of Cannabinoid Receptors CB1/
CB2
Irene Meliciani, Nicole Volz, Viktor Rempel, Sonja Hinz, Tadeusz Karcz,
Christa E. Mu¨ller, Stefan Bra¨se, Wolfgang Wenzel.
The cannabinoid receptors belong to the membrane-bound G protein-coupled
receptor superfamily and are predominantly coupled via Gi/o proteins. The
CB1 receptor subtype is known to play an essential role in analgesia,
memory-impairment, spasmolysis and regulation of appetite. Selective agonists
for CB2 receptors show antiinflammatory and analgesic properties in animal
models [1]. Cannabinoid receptors are activated by three major groups of li-
gands, mammalian endocannabinoids, plant and synthetic cannabinoids (e.g.
THC from the plant Cannabis sativa). Here we investigated the interactions be-
tween the cannabinoid receptors type 1 and 2 (CB1/CB2) with a novel set of
coumarin derivatives.
Rational drug design for many GPCRs is complicated by the lack of receptor
crystal structures. To aid interpretation of the experiments we have therefore
constructed a model for the CB1 and CB2 receptors based on homology to bo-
vine rhodopsin (pdb-code 1U19) and performed ligand binding simulations for
a family of 39 coumarin derivatives applying an all-atom docking protocol us-
ing Flexscreen [2].
